Salbutamol Completed Phase 1 Trials for Idiopathic Pulmonary Fibrosis (IPF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01457261IPF Drug Deposition Study